2 Big Risks and 2 Big Opportunities for Ginkgo Bioworks Stock [Yahoo! Finance]
Ginkgo Bioworks Holdings, Inc. (DNA)
Company Research
Source: Yahoo! Finance
To have the conviction to retain your shares through a dip, you'll also need to appreciate the upcoming opportunities that might make your patience worth the while. Ginkgo Bioworks (NYSE: DNA) is facing a pair of big risks right now, but it also has a pair of big opportunities that could be enough to turn its fortunes around. For reference, its shares are down by 90% this year so far. So let's dive in and examine the pitfalls and possibilities, to see whether its balance of risk to reward is likely to improve. These two intertwined risks could sink the stock The most ambitious part of Ginkgo's vision is to become a large-scale and hyperefficient manufacturer of bioengineered organisms, proteins, other biomolecules -- and laboratory data. It hopes to serve clients in biopharma, agriculture, and other sectors. It also plans to offer drug discovery services, as well as optimization services for engineered proteins and antibodies. All of those offerings are quite complicated to pr
Show less
Read more
Impact Snapshot
Event Time:
DNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DNA alerts
High impacting Ginkgo Bioworks Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
DNA
News
- Down a Monstrous 90% This Year, Is There Any Hope Left for Ginkgo Bioworks Investors? [Yahoo! Finance]Yahoo! Finance
- Ginkgo Regains Compliance with NYSE Minimum Bid Price Requirement [Yahoo! Finance]Yahoo! Finance
- Ginkgo Regains Compliance with NYSE Minimum Bid Price RequirementPR Newswire
- Pomerantz LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of Ginkgo Bioworks Holdings, Inc. Common Stock - DNAGlobeNewswire
- This 1 AI Stock Could Revolutionize Biotech and Pharma [Yahoo! Finance]Yahoo! Finance
DNA
Earnings
- 8/8/24 - Miss
DNA
Sec Filings
- 9/16/24 - Form 144
- 9/13/24 - Form 144
- 9/12/24 - Form 144
- DNA's page on the SEC website